Demonstrates crystal growth enhancement in Cs3Cu2I5, indicating improved radiation detection capabilities.
Cs3Cu2I5 single crystals are regarded as promising next-generation scintillators due to their large Stokes shift and low self-absorption characteristics. However, the cost-effective solution growth method faces critical challenges: the instability of colloidal precursors in solutions and the severe oxidation of Cu+ during crystal growth. This study innovatively introduces yttrium chloride (YCl3) as a dual-functional additive to address both issues simultaneously. The hydrolysis of YCl3 creates a controlled acidic environment, effectively suppressing the oxidation of Cu+; meanwhile, it enhances the stability of colloidal precursors by significantly increasing their surface charge and narrowing the particle size distribution. These synergistic effects enable the rapid growth (approximately 100 h) of near-centimeter-sized Cs3Cu2I5 single crystals with high crystallinity, without the need for inert gas protection. The optimized crystals exhibit exceptional performance: a photoluminescence quantum yield (PLQY) of 93.22% ± 0.47%, a scintillation decay time of 210.04 ns, and a light yield of ~738.14 pe/MeV. This YCl3-mediated growth strategy establishes an efficient approach for the solution-based synthesis of high-quality Cs3Cu2I5 single crystals, holding great significance for advancing high-sensitivity, environment-stable radiation detection applications such as medical diagnostics and nuclear safety monitoring.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: